Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
about
Extended-spectrum beta-lactamases: a clinical updateThe growing burden of antimicrobial resistance.Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms.Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomeRecent developments in beta lactamases and extended spectrum beta lactamases.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistanceImpact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection.ESBL-producing Enterobacteriaceae: controlling the spread of infection.Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in ManitobaFrequency and characteristics of infections caused by extended-spectrum beta-lactamase-producing organisms in neonates: a prospective cohort studyRisk factors for and outcomes associated with clinical isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals.Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital.Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions.Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan.Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.A case-control study of risk factors for urinary acquisition of Klebsiella pneumoniae producing CTX-M-15 in an outbreak situation in Sweden.Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States.
P2860
Q24534999-A29FAED5-75A2-4AA2-93CC-0DCAEF998BA5Q30371239-B58F9F53-5DC7-422B-A1F1-F27E09EE1142Q34073312-724E752D-A18A-4F6A-9631-39FB385624D4Q34351978-D7ADFA84-B963-42DB-B1D1-BBFAEB537EEEQ35590126-FEE97B39-A063-48B1-B3B9-4CC0FAD41110Q35840852-FE6755A2-81E1-47CB-BCFE-C9CABC070FC5Q35880482-66077F36-2A3A-476D-9F74-D6F6408191E7Q36152891-6136F905-913C-4055-9C67-D50695493B47Q36757737-244AD154-6996-4EA8-821F-45286A1B9D68Q36829662-CFAE0069-68BF-4529-963C-5C673334BAA8Q36852563-54D4DEBB-D8EC-4558-8A4A-4F212B9F0428Q36862658-368436A2-1FB8-47EC-92AF-9B2683A5494FQ36871054-08E25D5F-2E80-447F-B145-8891E26D55D5Q37224528-EAC21652-94C6-4104-8CB2-9CB585C30E9BQ37405325-F7196D85-A0EF-4760-8F53-C911F13078E1Q38271918-20E4FA2F-07B2-434D-ACBF-5EE0249FD09BQ39748390-790BE4BC-AE5B-400B-8762-7D9E17B60987Q40629064-68210F4D-61A3-45AB-ABB0-A473EC7C06DFQ41060308-951D46A4-337C-4FC5-BB62-A43D4D122EDAQ44510085-BE067BD9-21D0-4910-982B-3AB189AE7D1FQ46173410-189A874E-6D5B-4814-A4D2-6860F492DA04Q46643996-D614C51A-8E4C-40FD-93E3-9F426CE337D9Q53864729-41E329F5-63B4-4094-BBA3-C0BED3C90D9C
P2860
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@ast
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@en
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@nl
type
label
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@ast
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@en
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@nl
prefLabel
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@ast
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@en
Extended-spectrum beta-lactama ...... ns on colonization prevalence.
@nl
P2093
P2860
P356
P1476
Extended-spectrum beta-lactama ...... ons on colonization prevalence
@en
P2093
Ebbing Lautenbach
Jean Baldus Patel
Neil O Fishman
P2860
P304
P356
10.1086/502045
P577
2002-05-01T00:00:00Z